Special Issue of Journal of Business Research on Mobile Applications
Mobile Applications
Special Issue of Journal of Business Research
Software applications on mobile devices—or “mobile apps”—are a significant and growing force in each element of the marketing mix. Consider that in the United States:
• 77% of all adults own a smartphone (Pew, 2018)
• Time-spent in mobile apps grew 69% from 2016 to 2017
• Adults now spend more than five hours per day on their mobile devices (Flurry, 2017)
• 87% of mobile time spent is in applications. (App Annie, 2016)
Worldwide, mobile applications are projected to have 284 billion downloads and $100 billion in revenues in 2020 (App Annie, 2016). Despite the ubiquity of mobile devices and applications, and despite the tremendous impact of mobile apps on the economy, very little is understood about this unique consumption context.
Empirical data and academic research both support the notion that consumer choice and behavior is different in mobile applications versus other consumption contexts. Evidence shows that a number of factors affect consumer behavior “in-app,” including device type, application category, screen size, personality traits (Dinsmore, Dugan & Swani, 2017; Dinsmore, Swani, & Wamwara, 2018), design elements, pricing scheme (Arora, Hofstede, & Mahajan, 2017; Dinsmore, Dugan, & Wright, 2016) and more.
Due to the need for greater understanding of this important context, we invite submissions featuring both quantitative and qualitative studies relating to mobile applications, including (but not limited to):
• App promotion and adoption
• App Store Optimization (ASO)
• Cross-platform (in-app vs browser) and cross-device (phone vs tablet vs wearable vs IoT, etc.) behavior in applications
• Customer service via mobile application
• Design, device, and interface elements and their effect on user behavior
• Freemium models
• In-app advertising
• In-app purchases
• Promotions via mobile application
• Use of geolocation in marketing
Timeline: Submissions will be accepted beginning November 1, 2019 with final submissions accepted December 15th. Publication of the issue is anticipated in 2020.
Guest Editors
John Dinsmore, Wright State University (Managing Editor)
Kunal Swani, Wright State University
Kendall Goodrich, Wright State University
Umut Konas, University of Amsterdam
An Eye-Popping Price to Treat Blindness
Recently, a company called Spark Therapeutics announced its recently approved gene therapy ("Luxturna") for a rare form of hereditary blindness (biallelic RPE65 mutation-associated retinal dystrophy). The good news? It works. The bad news? The price: $425,000 per eye or $850,000 total.
Ethical issues aside, is this a good price for this product to optimize revenue for Spark?
The company CEO said he thought the pricing was "reflective of the value inherent in the therapy." In a classic marketing context, the CEO is referring to the economic value of the treatment in how they set the price. In other words, if you had access to $850K and were going blind, Spark thinks you would give up that amount of money to regain site. He's right. If I had access to $850K and was suffering from this form of blindness, I would fork it over in a heartbeat.
Problem....I don't have access to $850K. Most do not. And, unless this disease disproportionately affects the wealthy, it begs the question of what insurance companies will cover for the 1,000-2,000 people in the US who have this disorder. In an insurance system that routinely refuses to pay for lower-cost items such as weight-loss surgery, it's hard to imagine insurers will pony up for this. For frame of reference, the average cost of treating cancer is around $50,000.
In fact, this therapy will only incentivize insurance companies to do two things:
1. Push lower cost, alternative therapies such as drugs currently in trial for this same syndromes, and
2. Require genetic screening as a condition of coverage
When you consider the ability of consumers to pay for this treatment and the willingness of insurance companies to cover this cost, it seems the value of Luxturna is less about the drug itself and more about its ability to act as a foundation of future gene therapies.
Also, a friend pointed me to this article on combatting medical debt. Check it out if that’s a topic of interest.
The Behavioral Pricing Principle that Made Tesla Possible
I was just reading Rolling Stone's excellent profile of Elon Musk. And it got me thinking about the magic of Tesla and how Musk was able to break-through in electric cars.
Electric cars have been around for decades as novelties. In the 90s, The Simpsons parodied green vehicles as the obscure novelties that they were at the time. So, how did Musk do it? Two things:
1. He understood different potential segments in the green car market. Desire for a "green car" was not just a desire for value as most thought. Desire for a green car was also driven by a desire for a more sustainable planet. But, what is a predictor of environmental concern? Education. And education is still the greatest predictor of income. So, the people most likely to seek out a green car were more likely to be more educated and have a higher income.
2. The additional cost of an electric car over a gas-powered would not seem like that much if it was put in a more expensive car. Daniel Kahnemann and Amos Tversky won a Nobel Prize for discovering the principle of "diminishing sensitivity". What that principle states is that people judge price changes relative to the original price. So, if you are paying $1 for a beverage, and the price goes up fifty cents, that will seem like an outrage. But if you are paying $10 for a beverage and the price goes up fifty cents, you might not even notice. SO, instead of trying to take a $20,000 gas-powered Honda Civic and make it into a $27,000 electric Civic, those buyers are going to be really struck by the price increase. But, if you take a $70,000 gas-powered car and make it a $77,000 car, they aren't going to think twice about it.
It's the reason why, as smartphones have become more expensive people have started blowing out their options for those phones--more memory, bigger screens, etc. These options seem less expensive relative to the overall higher sticker price of a phone.
So, to recap: there was a desire among high-income people for a green car. At a high price point, these consumers might not even notice the price difference between a a gas vehicle and its electric alternative. That is what Michael Porter would call "fit" between a company, it's resources and the market.
The never-ending process of marketing...Insights-Action-Results-Repeat
Whether it's talking to students or clients, there is one common misconception of marketing: Once you develop a marketing plan to launch a company, that's kinda it. You launch. You declare victory. And then, you retire to your yacht with untold riches.
But the truth is much more daunting. The process of marketing never ends. There is always a next step to take with your customers and prospects. When someone makes a purchase from you, that's just the beginning of your relationship. And, like all relationships, you have to work to enhance and preserve that relationship so that it stands the tests of time and inevitable change. So, what is the process of marketing?
INSIGHTS: Learn all you can about you market. Many of these sources of information can be informal such as: conversations you've had customers, prospects, partners or news articles and blogs from people you respects. Other sources can be more formal: research reports from secondary sources, analysis of internal data or proprietary market research you conduct.
ACTION: From this intelligence you've gathered, there should actions that need to be taken. And, in many cases, the intelligence will SCREAM at you to employ certain tactics. In other cases, the intel's inferences may be more subtle. But either way, you have become smarter about your business and now you must put that newfound intellectual capital to work. Inaction, in this instance, would equal malpractice.
RESULTS: Once you have implemented these actions, you must be very careful to document and measure your actual results and compare them to the results you expected prior to taking actions. Spoiler alert: You will be wrong to some degree. You could be wrong in a very pleasant way and surpass you expectations. Even so, connecting your intel to actions and comparing what you thought would happen with what actually happen is the first step in generating intelligence for the next go around.
REPEAT: As you learn from the results, you will acquire new knowledge. You will also identify gaps in your knowledge of which you had been unaware. As you re-enter the Insight phase, work to fill those gaps and apply the knowledge you gained from the results of your last campaign.